Cutaneous Leishmaniasis
📧 Sign up to get email alerts when something new happens for Cutaneous Leishmaniasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-01-04FDA Approved: IMPAVIDO — Supplemental Application (Profounda, Inc.)
FDA approved a supplemental application for IMPAVIDO (miltefosine) from Profounda, Inc. under NDA204684, expanding its approved use. This ac…